Lamictal vs. Namenda

Summary

We compare the side effects and drug effectiveness of Lamictal and Namenda. The study is created by eHealthMe based on reports of 117,317 people who take Lamictal and Namenda, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on lamotrigine and memantine hydrochloride (the active ingredients of Lamictal and Namenda, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered.

What is Lamictal?

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 64,115 users)

What is Namenda?

Namenda has active ingredients of memantine hydrochloride. It is often used in dementia. (latest outcomes from Namenda 11,786 users)

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 22, 2019

117,317 people who take Lamictal and Namenda are studied.


Number of reports submitted per year:

Lamictal vs Namenda drug comparison reports.

Drugs in this study:

  • Lamictal (lamotrigine)
  • Namenda (memantine hydrochloride)

Most common side effects:

Lamictal:
  1. Confusional State
  2. Fall
  3. Dizziness
  4. Somnolence (a state of near-sleep, a strong desire for sleep)
  5. Fatigue (feeling of tiredness)
  6. Asthenia (weakness)
  7. Nausea (feeling of having an urge to vomit)
  8. Drug Ineffective
  9. Agitation (state of anxiety or nervous excitement)
  10. Diarrhoea
Namenda:
  1. Rash
  2. Drug Ineffective
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Pyrexia (fever)
  5. Nausea (feeling of having an urge to vomit)
  6. Headache (pain in head)
  7. Dizziness
  8. Fatigue (feeling of tiredness)
  9. Depression
  10. Vomiting

Most common side effects experienced by people in long term use:

Lamictal:
  1. Fall
  2. Confusional State
  3. Urinary Tract Infection
  4. Aggression
  5. Agitation (state of anxiety or nervous excitement)
  6. Hallucination (an experience involving the perception of something not present)
  7. Dizziness
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  10. Pneumonia
Namenda:
  1. Rash
  2. Depression
  3. Drug Ineffective
  4. Anxiety
  5. Dizziness
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Fatigue (feeling of tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Headache (pain in head)
  10. Insomnia (sleeplessness)

Drug effectiveness:

Lamictal:
  • not at all: 18.05 %
  • somewhat: 40.11 %
  • moderate: 26.07 %
  • high: 13.47 %
  • very high: 2.29 %
Namenda:
  • not at all: 3.47 %
  • somewhat: 18.19 %
  • moderate: 30.76 %
  • high: 31.12 %
  • very high: 16.45 %

Do you take Lamictal or Namenda?

You are not alone:




Related publications that referenced our studies

Related studies:



Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.